Mirk/Dyrk1B modulates the development of chemoresistance in human ovarian cancer.

被引：0
|
作者：
Gao, Jingchun [1 ]
Li, Ji [1 ]
Gao, Heli [2 ]
Tian, Jianxin [1 ]
Lv, Yunyi [1 ]
Yang, Zhihai [1 ]
Zhang, Qiuping [2 ]
Kong, Fandou [1 ]
Pang, Jian [1 ]
Guan, Hongwei [2 ]
Shi, Hong [1 ]
机构：
[1] Dalian Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Dalian, Liaoning, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 1, Dept Pathol, Dalian, Liaoning, Peoples R China
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3376
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3376
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome
    Ashford, Anne L.
    Dunkley, Tom P. J.
    Cockerill, Mark
    Rowlinson, Rachel A.
    Baak, Lisa M.
    Gallo, Raffaella
    Balmanno, Kathryn
    Goodwin, Louise M.
    Ward, Richard A.
    Lochhead, Pamela A.
    Guichard, Sylvie
    Hudson, Kevin
    Cook, Simon J.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (04) : 883 - 900
  • [32] Mirk/dyrk1B facilitates cell survival by modulating localization and function of the CDK inhibitor p21
    Mercer, SE
    FASEB JOURNAL, 2005, 19 (04): : A805 - A805
  • [33] Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome
    Anne L. Ashford
    Tom P. J. Dunkley
    Mark Cockerill
    Rachel A. Rowlinson
    Lisa M. Baak
    Raffaella Gallo
    Kathryn Balmanno
    Louise M. Goodwin
    Richard A. Ward
    Pamela A. Lochhead
    Sylvie Guichard
    Kevin Hudson
    Simon J. Cook
    Cellular and Molecular Life Sciences, 2016, 73 : 883 - 900
  • [34] Differential regulation of expression of the protein kinases DYRK1A and DYRK1B in cancer cells
    Vorwerk, Vincent Andreas
    Wilms, Gerrit
    Babendreyer, Aaron
    Becker, Walter
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [35] Mirk/Dyrk1b在上皮性卵巢癌组织中的表达及意义
    杨湘军
    高景春
    殷平
    胡文峰
    廖洪锋
    缪智辉
    潘超
    李娜
    中国妇幼保健, 2011, 26 (35) : 5614 - 5616
  • [36] Mirk/Dyrk1B mediates cell survival and G0/G1 phase of cell cycle via interacting with MAPK/ERK pathway in human cancer cells
    Gao, Jingchun
    CANCER RESEARCH, 2012, 72
  • [37] Novel Role of Titin in the Development of Chemoresistance in Ovarian Cancer.
    Harper, Amy K.
    Fletcher, Nicole M.
    Fan, Rong
    Morris, Robert
    Saed, Ghassan M.
    REPRODUCTIVE SCIENCES, 2019, 26 : 159A - 159A
  • [38] Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2
    Hu, Jing
    Nakhla, Hassan
    Friedman, Eileen
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (02) : 307 - 318
  • [39] Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis
    Chen, Yingying
    Wang, Shuo
    He, Zhixian
    Sun, Fulan
    Huang, Yeqing
    Ni, Qichao
    Wang, Hua
    Wang, Yingying
    Cheng, Chun
    HUMAN PATHOLOGY, 2017, 66 : 48 - 58
  • [40] DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer
    Brichkina, Anna
    Ems, Miriam
    Suezov, Roman
    Singh, Rajeev
    Lutz, Veronika
    Picard, Felix S. R.
    Nist, Andrea
    Stiewe, Thorsten
    Graumann, Johannes
    Daude, Michael
    Diederich, Wibke E.
    Finkernagel, Florian
    Chung, Ho-Ryun
    Bartsch, Detlef K.
    Roth, Katrin
    Keber, Corinna
    Denkert, Carsten
    Huber, Magdalena
    Gress, Thomas M.
    Lauth, Matthias
    GUT, 2024, 73 (10) : 1684 - 1701
12345